Remdesivir (COVID-19) Market - Global Outlook and Forecast 2021-2027

Remdesivir (COVID-19) Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687512 | No. of Pages: 91 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021
This report contains market size and forecasts of Remdesivir (COVID-19) in global, including the following market information:
Global Remdesivir (COVID-19) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Remdesivir (COVID-19) Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Remdesivir (COVID-19) companies in 2020 (%)
The global Remdesivir (COVID-19) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Remdesivir (COVID-19) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Remdesivir (COVID-19) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Remdesivir (COVID-19) Market Segment Percentages, By Type, 2020 (%)
5mg
10mg
50mg
100mg

Global Remdesivir (COVID-19) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Remdesivir (COVID-19) Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinics
Drug Store
Others

Global Remdesivir (COVID-19) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Remdesivir (COVID-19) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Remdesivir (COVID-19) revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Remdesivir (COVID-19) revenues share in global market, 2020 (%)
Key companies Remdesivir (COVID-19) sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Remdesivir (COVID-19) sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Borui Bio-Pharmaceutical
Berry Global Group
Inovio Pharmaceuticals
1 Introduction to Research & Analysis Reports
    1.1 Remdesivir (COVID-19) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Remdesivir (COVID-19) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Remdesivir (COVID-19) Overall Market Size
    2.1 Global Remdesivir (COVID-19) Market Size: 2021 VS 2027
    2.2 Global Remdesivir (COVID-19) Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Remdesivir (COVID-19) Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Remdesivir (COVID-19) Players in Global Market
    3.2 Top Global Remdesivir (COVID-19) Companies Ranked by Revenue
    3.3 Global Remdesivir (COVID-19) Revenue by Companies
    3.4 Global Remdesivir (COVID-19) Sales by Companies
    3.5 Global Remdesivir (COVID-19) Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Remdesivir (COVID-19) Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Remdesivir (COVID-19) Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Remdesivir (COVID-19) Players in Global Market
        3.8.1 List of Global Tier 1 Remdesivir (COVID-19) Companies
        3.8.2 List of Global Tier 2 and Tier 3 Remdesivir (COVID-19) Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Remdesivir (COVID-19) Market Size Markets, 2021 & 2027
        4.1.2 5mg
        4.1.3 10mg
        4.1.4 50mg
        4.1.5 100mg
    4.2 By Type - Global Remdesivir (COVID-19) Revenue & Forecasts
        4.2.1 By Type - Global Remdesivir (COVID-19) Revenue, 2016-2021
        4.2.2 By Type - Global Remdesivir (COVID-19) Revenue, 2022-2027
        4.2.3 By Type - Global Remdesivir (COVID-19) Revenue Market Share, 2016-2027
    4.3 By Type - Global Remdesivir (COVID-19) Sales & Forecasts
        4.3.1 By Type - Global Remdesivir (COVID-19) Sales, 2016-2021
        4.3.2 By Type - Global Remdesivir (COVID-19) Sales, 2022-2027
        4.3.3 By Type - Global Remdesivir (COVID-19) Sales Market Share, 2016-2027
    4.4 By Type - Global Remdesivir (COVID-19) Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Remdesivir (COVID-19) Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Clinics
        5.1.4 Drug Store
        5.1.5 Others
    5.2 By Application - Global Remdesivir (COVID-19) Revenue & Forecasts
        5.2.1 By Application - Global Remdesivir (COVID-19) Revenue, 2016-2021
        5.2.2 By Application - Global Remdesivir (COVID-19) Revenue, 2022-2027
        5.2.3 By Application - Global Remdesivir (COVID-19) Revenue Market Share, 2016-2027
    5.3 By Application - Global Remdesivir (COVID-19) Sales & Forecasts
        5.3.1 By Application - Global Remdesivir (COVID-19) Sales, 2016-2021
        5.3.2 By Application - Global Remdesivir (COVID-19) Sales, 2022-2027
        5.3.3 By Application - Global Remdesivir (COVID-19) Sales Market Share, 2016-2027
    5.4 By Application - Global Remdesivir (COVID-19) Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Remdesivir (COVID-19) Market Size, 2021 & 2027
    6.2 By Region - Global Remdesivir (COVID-19) Revenue & Forecasts
        6.2.1 By Region - Global Remdesivir (COVID-19) Revenue, 2016-2021
        6.2.2 By Region - Global Remdesivir (COVID-19) Revenue, 2022-2027
        6.2.3 By Region - Global Remdesivir (COVID-19) Revenue Market Share, 2016-2027
    6.3 By Region - Global Remdesivir (COVID-19) Sales & Forecasts
        6.3.1 By Region - Global Remdesivir (COVID-19) Sales, 2016-2021
        6.3.2 By Region - Global Remdesivir (COVID-19) Sales, 2022-2027
        6.3.3 By Region - Global Remdesivir (COVID-19) Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Remdesivir (COVID-19) Revenue, 2016-2027
        6.4.2 By Country - North America Remdesivir (COVID-19) Sales, 2016-2027
        6.4.3 US Remdesivir (COVID-19) Market Size, 2016-2027
        6.4.4 Canada Remdesivir (COVID-19) Market Size, 2016-2027
        6.4.5 Mexico Remdesivir (COVID-19) Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Remdesivir (COVID-19) Revenue, 2016-2027
        6.5.2 By Country - Europe Remdesivir (COVID-19) Sales, 2016-2027
        6.5.3 Germany Remdesivir (COVID-19) Market Size, 2016-2027
        6.5.4 France Remdesivir (COVID-19) Market Size, 2016-2027
        6.5.5 U.K. Remdesivir (COVID-19) Market Size, 2016-2027
        6.5.6 Italy Remdesivir (COVID-19) Market Size, 2016-2027
        6.5.7 Russia Remdesivir (COVID-19) Market Size, 2016-2027
        6.5.8 Nordic Countries Remdesivir (COVID-19) Market Size, 2016-2027
        6.5.9 Benelux Remdesivir (COVID-19) Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Remdesivir (COVID-19) Revenue, 2016-2027
        6.6.2 By Region - Asia Remdesivir (COVID-19) Sales, 2016-2027
        6.6.3 China Remdesivir (COVID-19) Market Size, 2016-2027
        6.6.4 Japan Remdesivir (COVID-19) Market Size, 2016-2027
        6.6.5 South Korea Remdesivir (COVID-19) Market Size, 2016-2027
        6.6.6 Southeast Asia Remdesivir (COVID-19) Market Size, 2016-2027
        6.6.7 India Remdesivir (COVID-19) Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Remdesivir (COVID-19) Revenue, 2016-2027
        6.7.2 By Country - South America Remdesivir (COVID-19) Sales, 2016-2027
        6.7.3 Brazil Remdesivir (COVID-19) Market Size, 2016-2027
        6.7.4 Argentina Remdesivir (COVID-19) Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Remdesivir (COVID-19) Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Remdesivir (COVID-19) Sales, 2016-2027
        6.8.3 Turkey Remdesivir (COVID-19) Market Size, 2016-2027
        6.8.4 Israel Remdesivir (COVID-19) Market Size, 2016-2027
        6.8.5 Saudi Arabia Remdesivir (COVID-19) Market Size, 2016-2027
        6.8.6 UAE Remdesivir (COVID-19) Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Gilead Sciences
        7.1.1 Gilead Sciences Corporate Summary
        7.1.2 Gilead Sciences Business Overview
        7.1.3 Gilead Sciences Remdesivir (COVID-19) Major Product Offerings
        7.1.4 Gilead Sciences Remdesivir (COVID-19) Sales and Revenue in Global (2016-2021)
        7.1.5 Gilead Sciences Key News
    7.2 Bright Gene
        7.2.1 Bright Gene Corporate Summary
        7.2.2 Bright Gene Business Overview
        7.2.3 Bright Gene Remdesivir (COVID-19) Major Product Offerings
        7.2.4 Bright Gene Remdesivir (COVID-19) Sales and Revenue in Global (2016-2021)
        7.2.5 Bright Gene Key News
    7.3 Hainan Haiyao
        7.3.1 Hainan Haiyao Corporate Summary
        7.3.2 Hainan Haiyao Business Overview
        7.3.3 Hainan Haiyao Remdesivir (COVID-19) Major Product Offerings
        7.3.4 Hainan Haiyao Remdesivir (COVID-19) Sales and Revenue in Global (2016-2021)
        7.3.5 Hainan Haiyao Key News
    7.4 Kelun Pharma
        7.4.1 Kelun Pharma Corporate Summary
        7.4.2 Kelun Pharma Business Overview
        7.4.3 Kelun Pharma Remdesivir (COVID-19) Major Product Offerings
        7.4.4 Kelun Pharma Remdesivir (COVID-19) Sales and Revenue in Global (2016-2021)
        7.4.5 Kelun Pharma Key News
    7.5 Hunan Warrant Pharmaceutical
        7.5.1 Hunan Warrant Pharmaceutical Corporate Summary
        7.5.2 Hunan Warrant Pharmaceutical Business Overview
        7.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Major Product Offerings
        7.5.4 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales and Revenue in Global (2016-2021)
        7.5.5 Hunan Warrant Pharmaceutical Key News
    7.6 Borui Bio-Pharmaceutical
        7.6.1 Borui Bio-Pharmaceutical Corporate Summary
        7.6.2 Borui Bio-Pharmaceutical Business Overview
        7.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Major Product Offerings
        7.6.4 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales and Revenue in Global (2016-2021)
        7.6.5 Borui Bio-Pharmaceutical Key News
    7.7 Berry Global Group
        7.7.1 Berry Global Group Corporate Summary
        7.7.2 Berry Global Group Business Overview
        7.7.3 Berry Global Group Remdesivir (COVID-19) Major Product Offerings
        7.4.4 Berry Global Group Remdesivir (COVID-19) Sales and Revenue in Global (2016-2021)
        7.7.5 Berry Global Group Key News
    7.8 Inovio Pharmaceuticals
        7.8.1 Inovio Pharmaceuticals Corporate Summary
        7.8.2 Inovio Pharmaceuticals Business Overview
        7.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Major Product Offerings
        7.8.4 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales and Revenue in Global (2016-2021)
        7.8.5 Inovio Pharmaceuticals Key News
8 Global Remdesivir (COVID-19) Production Capacity, Analysis
    8.1 Global Remdesivir (COVID-19) Production Capacity, 2016-2027
    8.2 Remdesivir (COVID-19) Production Capacity of Key Manufacturers in Global Market
    8.3 Global Remdesivir (COVID-19) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Remdesivir (COVID-19) Supply Chain Analysis
    10.1 Remdesivir (COVID-19) Industry Value Chain
    10.2 Remdesivir (COVID-19) Upstream Market
    10.3 Remdesivir (COVID-19) Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Remdesivir (COVID-19) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com